Our system has noticed that you are based in , but the current country setting is . Do you still want to change your country?

1 2 3 4 5

Press Photos

Please note our terms of use governing the use of press images.By downloading the images from our media database, you agree to these terms of use: Press images may only be used for press purposes (print, electronic media, online) and exclusively in the context of the associated press release and may not be edited. The picture credits (source: Wacker Chemie AG) are mandatory. Images deleted from the media database may no longer be used in the future. If a press photo is used, a copy of the publication or a link to the publication is requested. Otherwise, the copyright information www.wacker.com/disclaimer applies.

press pictures

GENIOPLAST® PE50S08

WACKER will present a new silicone-based additive masterbatch for com-pounding polyethylene at K 2022. GENIOPLAST® PE50S08 facilitates the manufacture of ready-to-use polyethylene molding compounds and improves the surface properties of the resulting plastic products.

Download picture (JPG, 4.0 MB)
press pictures

LIOSIL® Lotus Effect

Silicone fluids and emulsions are important additives for the consumer goods industry, where their uses include textile impregnation. WACKER is now marketing these products under the LIOSIL® brand.

Download picture (JPG, 96 KB)
press pictures

LIOSIL® Tissues

Applications for silicone fluids and emulsions include their use as important additives for consumer goods. Sanitary paper and tissues, for instance, are frequently coated with silicones to make them feel pleasantly soft and to prevent scratchiness. WACKER will be marketing these silicones under the LIOSIL® brand name.

Download picture (JPG, 30 KB)
press pictures

WACKER Barista Solutions

WACKER Cyclodextrins Improve the Foaming of Barista Toppings

Download picture (JPG, 81 KB)
press pictures

Wacker Biotech Dr. Susanne Leonhartsberger

Dr. Susanne Leonhartsberger has been the managing director of Wacker Biotech GmbH since 2017, and, in her capacity as the head of the Biopharmaceuticals business line, is responsible for WACKER’s biologics business. “What especially motivates me is that we’re providing innovative medications for sick people all over the world – and that’s how most of us feel,” the biologist observes. (Photo: Wacker Chemie AG)

Download picture (JPG, 1.4 MB)
1 2 3 4 5